Villere ST Denis J & Co. LLC trimmed its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 0.5% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 480,807 shares of the biotechnology company’s stock after selling 2,540 shares during the […]
AMI Asset Management Corp increased its position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 33.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 27,892 shares of the biotechnology company’s stock after acquiring an additional 7,015 shares during the quarter. […]
AMI Asset Management Corp raised its stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 33.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 27,892 shares of the biotechnology company’s stock after acquiring an additional 7,015 shares during the quarter. AMI […]
Chicago Capital LLC grew its stake in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 40.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 449,508 shares of the biotechnology company’s stock after acquiring an additional 130,454 […]
StockNews.com upgraded shares of Ligand Pharmaceuticals (NASDAQ:LGND – Get Rating) from a hold rating to a buy rating in a research note issued to investors on Saturday. A number of other brokerages have also commented on LGND. HC Wainwright raised their price target on Ligand Pharmaceuticals from $135.00 to $144.00 in a research note on […]